Lv1
38 积分 2025-07-11 加入
In vivo generation of CAR myeloid cells through erythrocyte-mediated mRNA delivery for cancer immunotherapy
15天前
已完结
In vivo generation of CAR myeloid cells through erythrocyte-mediated mRNA delivery for cancer immunotherapy
1个月前
已完结
‘Off-the-shelf’ allogeneic CAR T cells: development and challenges
2个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
3个月前
已完结
In Vitro and In Vivo Activity of a Lipid Nanoparticle System for the In Vivo Generation of CAR T Cells
3个月前
已关闭
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
3个月前
已关闭
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
3个月前
已完结
Manufacturing chimeric antigen receptor T cells: issues and challenges
3个月前
已完结
Three-in-One Peptide Prodrug with Targeting, Assembly and Release Properties for Overcoming Bacterium-Induced Drug Resistance and Potentiating Anti-Cancer Immune Response
10个月前
已完结
皖公网安备34019202002308
